» Articles » PMID: 23780507

Epidemiology of Community-associated Clostridium Difficile Infection, 2009 Through 2011

Abstract

Importance: Clostridium difficile infection (CDI) has been increasingly reported among healthy individuals in the community. Recent data suggest that community-associated CDI represents one-third of all C difficile cases. The epidemiology and potential sources of C difficile in the community are not fully understood.

Objectives: To determine epidemiological and clinical characteristics of community-associated CDI and to explore potential sources of C difficile acquisition in the community.

Design And Setting: Active population-based and laboratory-based CDI surveillance in 8 US states.

Participants: Medical records were reviewed and interviews performed to assess outpatient, household, and food exposures among patients with community-associated CDI (ie, toxin or molecular assay positive for C difficile and no overnight stay in a health care facility within 12 weeks). Molecular characterization of C difficile isolates was performed. Outpatient health care exposure in the prior 12 weeks among patients with community-associated CDI was a priori categorized into the following 3 levels: no exposure, low-level exposure (ie, outpatient visit with physician or dentist), or high-level exposure (ie, surgery, dialysis, emergency or urgent care visit, inpatient care with no overnight stay, or health care personnel with direct patient care).

Main Outcomes And Measures: Prevalence of outpatient health care exposure among patients with community-associated CDI and identification of potential sources of C difficile by level of outpatient health care exposure.

Results: Of 984 patients with community-associated CDI, 353 (35.9%) did not receive antibiotics, 177 (18.0%) had no outpatient health care exposure, and 400 (40.7%) had low-level outpatient health care exposure. Thirty-one percent of patients without antibiotic exposure received proton pump inhibitors. Patients having CDI with no or low-level outpatient health care exposure were more likely to be exposed to infants younger than 1 year (P = .04) and to household members with active CDI (P = .05) compared with those having high-level outpatient health care exposure. No association between food exposure or animal exposure and level of outpatient health care exposure was observed. North American pulsed-field gel electrophoresis (NAP) 1 was the most common (21.7%) strain isolated; NAP7 and NAP8 were uncommon (6.7%).

Conclusions And Relevance: Most patients with community-associated CDI had recent outpatient health care exposure, and up to 36% would not be prevented by reduction of antibiotic use only. Our data support evaluation of additional strategies, including further examination of C difficile transmission in outpatient and household settings and reduction of proton pump inhibitor use.

Citing Articles

Abundant geographical divergence of Clostridioides difficile infection in China: a prospective multicenter cross-sectional study.

Bai L, Xu T, Zhang W, Jiang Y, Gu W, Zhao W BMC Infect Dis. 2025; 25(1):185.

PMID: 39920584 PMC: 11806848. DOI: 10.1186/s12879-025-10552-y.


Patient Satisfaction Scale Following a Laxative for Antibiotic Washout Prior to Oral Microbiome Therapy.

Chua H, Pham S, Lombardi D, Hot E, Mody L Adv Ther. 2024; 42(1):490-499.

PMID: 39607629 PMC: 11782395. DOI: 10.1007/s12325-024-03065-8.


A call to action: the SHEA research agenda to combat healthcare-associated infections.

Kwon J, Advani S, Branch-Elliman W, Braun B, Cheng V, Chiotos K Infect Control Hosp Epidemiol. 2024; 1-18.

PMID: 39448369 PMC: 11518679. DOI: 10.1017/ice.2024.125.


Molecular Epidemiology of Colonization in Families With Infants.

Marlow C, Clayton J, Minich N, Golonka G, Maruskin L, Jencson A Open Forum Infect Dis. 2024; 11(6):ofae299.

PMID: 38911950 PMC: 11192056. DOI: 10.1093/ofid/ofae299.


Incidence, Clinical Characteristics, and Outcomes of Clostridium difficile Infection in a Tertiary Care Center in Bahrain.

Alkhawaja S, Abo Arisheh T, Acunin R, Alawi F, Sharaf A, Alawainati M Cureus. 2024; 16(4):e57381.

PMID: 38699115 PMC: 11063807. DOI: 10.7759/cureus.57381.